Verified Nov 2026
Electronics & Software
·

Lincoln, Nebraska
·
Since 2010
Celerion is an early-phase clinical research organization headquartered in Lincoln, Nebraska, founded in 2010. The company employs 1,000–5,000 people and serves the pharmaceutical, biotechnology, automotive, electric-vehicle, and medical device industries. It operates over 650 clinical beds across facilities in the United States, Europe, and Asia, and has conducted more than 6,000 clinical studies.
Celerion at a glance
Revenue
$250-500M
Est. band
Employees
1,000-5,000
Founded
2010
Headquarters
Lincoln, Nebraska
Industries
Automotive
Electric Vehicles
Medical
Overview
Celerion is an early-phase clinical research organization headquartered in Lincoln, Nebraska, founded in 2010. The company employs 1,000–5,000 people and serves the pharmaceutical, biotechnology, automotive, electric-vehicle, and medical device industries. It operates over 650 clinical beds across facilities in the United States, Europe, and Asia, and has conducted more than 6,000 clinical studies.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Lincoln, Nebraska |
Employees | 1,000-5,000 |
Revenue | $250-500M (estimated) |
Primary capability | Electronics & Software |
What Celerion makes
The company provides First-in-Human studies, Proof-of-Concept studies, cardiovascular safety assessments, applied translational medicine, clinical pharmacology, bioanalytical services, and regulatory support.
Products and capabilities described on the company's own site include LED (source: celerion.com).
Latest developments
2026-10-26 — Celerion global leadership visits iREACH Health as Queen’s and Celerion formally | News | Queen's University Belfast (qub.ac.uk)
2026-06-25 — Celerion Expands Zurich Bioanalytical Laboratory to Meet Growing Market Demand | Celerion (celerion.com)
2026-04-22 — Celerion Announces Majority Investment from THL Partners - THL (thl.com)
2026-04-22 — H.I.G. Capital Announces the Sale of Celerion - H.I.G. Capital - Global Alternative Assets Investment Firm (hig.com)
2026-04-22 — THL Partners to Acquire Pharmaceutical Research Organization Celerion From H.I.G. Capital | Paul, Weiss (paulweiss.com)
2026-01-21 — News & Events | Celerion (celerion.com)
Company details
Celerion operates global network of early-phase clinical research operations, with capacity to recruit participants and support drug development across multiple therapeutic areas. Celerion was founded in 2010, has an estimated 1,000-5,000 employees, and is headquartered in Lincoln, Nebraska.
Frequently asked questions
What does Celerion make?
Celerion is an early-phase clinical research organization headquartered in Lincoln, Nebraska, founded in 2010. The company employs 1,000–5,000 people and serves the pharmaceutical, biotechnology, automotive, electric-vehicle, and medical device industries. It operates over 650 clinical beds across facilities in the United States, Europe, and Asia, and has conducted more than 6,000 clinical studies.
Where is Celerion headquartered?
Celerion is headquartered in Lincoln, Nebraska (621 Rose Street, Lincoln, Nebraska, 68502).
When was Celerion founded?
Celerion was founded in 2010.
How big is Celerion?
Celerion has an estimated 1,000-5,000 employees, with revenue in the $250-500M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
